| Autor: |
Golconda MS; Division of Nephrology and Internal Medicine, Mayo Clinic Rochester, MN 55905, USA., Larson TS, Kolb LG, Kumar R |
| Jazyk: |
angličtina |
| Zdroj: |
Mayo Clinic proceedings [Mayo Clin Proc] 1996 Jan; Vol. 71 (1), pp. 32-6. |
| DOI: |
10.4065/71.1.32 |
| Abstrakt: |
Hypercalcemia occurs in 10 to 30% of renal transplant recipients and is most often due to persistent hyperparathyroidism. Herein we describe a patient with a history of hyperparathyroidism who sought medical assessment because of recurrence of hypercalcemia 7 years after a successful renal transplantation. The hypercalcemia was associated with a normal serum phosphate level, a low to normal parathyroid hormone level, virtually undetectable levels of parathyroid hormone-related protein, and increased 1,25-dihydroxyvitamin D levels. Further assessment led to the diagnosis of an underlying lymphoma. To our knowledge, this is the first report of 1,25-dihydroxyvitamin D-mediated hypercalcemia in a renal transplant recipient with lymphoma. The possibility of an underlying lymphoproliferative disorder should be considered in the differential diagnosis of hypercalcemia in a renal transplant recipient. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
